Long-term effect of mavacamten in obstructive hypertrophic cardiomyopathy
Most Cited Paper
in Heart Failure Treatment and Management
18 Months Post-Publication
Class of 2026
“Long-term effect of mavacamten in obstructive hypertrophic cardiomyopathy”
A research intelligence initiative by Pepkio
pri.pepkio.com
Topics
mavacamten · obstructive hypertrophic cardiomyopathy · MAVA-LTE · EXPLORER-HCM · left ventricular outflow tract gradient · NT-proBNP · Left ventricular ejection fraction · NYHA functional class · EQ-5D-5L · reversible LVEF reduction · long-term safety · sustained symptom improvement
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Heart Failure Treatment and Management Papers, Class of 2026. https://pri.pepkio.com/top-papers/heart-failure-treatment-and-management/2026. Accessed 2026-08-20. Methodology Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459